Formoterol fumarate dihydrate
Formoterol fumarate dihydrate Basic information
- Product Name:
- Formoterol fumarate dihydrate
- Synonyms:
-
- Formamide, N-(2-hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, rel-, (2E)-2-butenedioate (2:1) (salt), dihydrate
- Unii-W34shf8J2k
- (±)-(R,R)-N-[2-Hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamidehemifumarate
- Formoterol fumarate dihydrate ,98.5%
- (r*,r*)-n-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide fumarate dihydrate
- Formoterol fumarate dihydrate
- Formoterol Fumarate (100 mg)
- forMaMide fuMarate dihydrate
- CAS:
- 183814-30-4
- MF:
- C23H28N2O8
- MW:
- 460.48
- Product Categories:
-
- Other APIs
- API
- Aromatics
- Chiral Reagents
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Mol File:
- 183814-30-4.mol
Formoterol fumarate dihydrate Chemical Properties
- Melting point:
- 116-120°C
- storage temp.
- 2-8°C
- solubility
- DMSO: soluble20mg/mL
- form
- solid
- color
- white to off-white
- InChIKey
- RATSWNOMCHFQGJ-XODSYJLDSA-N
- SMILES
- C(/C(=O)O)=C\C(=O)O.[C@@H](C1C=CC(O)=C(NC=O)C=1)(O)CN[C@@H](C)CC1C=CC(OC)=CC=1 |&1:8,22,r|
- CAS DataBase Reference
- 183814-30-4
Formoterol fumarate dihydrate Usage And Synthesis
Chemical Properties
Pale Yellow Solid
Uses
Formoterol is a selective β2-adrenergic receptor agonist. Formoterol is used as an antiasthmatic.
Uses
ForMoterol FuMarate Dihydrate is a selective β2-adrenergic receptor agonist,it is used as an antiasthmatic.
Biological Activity
Potent, selective and long-acting β 2 -adrenoceptor agonist. Displays 330-fold selectivity for β 2 over β 1 receptors (pK d values are 8.12 and 5.58 respectively). Potently relaxes guinea pig trachea (pD 2 = 9.29), and is longer-acting and 100-fold more potent than salbutamol.
Biochem/physiol Actions
β2-Adrenoreceptor agonist.
Drug interactions
The efficacy and tolerability of glycopyrronium/formoterol fumarate metered dose inhaler, a fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate 14.4/10 μg (equivalent to glycopyrrolate/formoterol fumarate 18/9.6 μg) delivered by metered dose inhaler using innovative co-suspension delivery technology, was investigated in patients (n = 292) with COPD [12C]. There were no meaningful pharmacokinetic interactions, whether drug–drug or due to formulation, between glycopyrronium and formoterol following treatment with formulated using a new co-suspension delivery technology. The incidence of cardiovascular events of special interest was low (stroke, 0%–0.4%; cardiac ischemia, 0.4%–2.3%; cardiac failure, 1.3%–2.5%; arrhythmia, 1.3%–3.2%), and no important trends in clinical laboratory results, vital signs, or electrocardiograms were observed[1].
References
[1] Aagaard, Lise . "A worldwide yearly survey of new data in adverse drug reactions." (2014).
Formoterol fumarate dihydrateSupplier
- Tel
- +8615621883869 15621883869
- liutf@jewim.com.cn
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- info@syntechem.com
Formoterol fumarate dihydrate(183814-30-4)Related Product Information
- CHLOROPHOSPHONAZO III
- Chlorantraniliprole
- 1-Hydroxyethylidene-1,1-diphosphonic acid
- Arformoterol tartrate
- Fumaric acid
- Dimethyl fumarate
- Formoterol
- Ketotifen fumarate
- Benzamide
- 4-Ethyl-5-fluoro-6-hydroxypyrimidine
- N,N-Dimethylformamide
- Formamide
- Ferrous fumarate
- Formoterol fumarate
- FOROXYMITHINE
- FUMARATE
- Formoterol fumarate dihydrate